Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry R Davis

Showing results (61-70 of 185) with videos related to

Pageof 19
Sort By:
JAMA Internal Medicine|May 23, 2017
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical TrialBenjamin H Han, David Sutin, Jeff D Williamson, et al.
Plos One|April 4, 2012
Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT studyXue Zhang, Amy I Lynch, Barry R Davis, et al.
Journal of Hypertension|July 7, 2021
Sustained SBP control and long-term nursing home admission among Medicare beneficiariesC Barrett Bowling, Richard Sloane, Carl Pieper, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 8, 2006
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Linda B Piller, Charles E Ford, Barry R Davis, et al.
Drugs & Aging|August 7, 2015
Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-AnalysisMonica Teng, Liang Lin, Ying Jiao Zhao, et al.
Journal of General Internal Medicine|February 10, 2021
Association of Sustained Blood Pressure Control with Lower Risk for High-Cost Multimorbidities Among Medicare Beneficiaries in ALLHATC Barrett Bowling, Richard Sloane, Carl Pieper, et al.
Circulation|June 22, 2005
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) studyDonna K Arnett, Barry R Davis, Charles E Ford, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 1, 2014
Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real?Ravi V Shah, Siddique A Abbasi, José-Miguel Yamal, et al.
Journal of Hypertension|February 28, 2022
The Blood Pressure Lowering Treatment Trialists' Collaboration: methodological clarifications of recent reportsMilad Nazarzadeh, Dexter Canoy, Zeinab Bidel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 12, 2013
Visit-to-visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly ProgramJohn B Kostis, Jeanine E Sedjro, Javier Cabrera, et al.
Pageof 19

Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
JAMA Internal Medicine|May 23, 2017
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical TrialBenjamin H Han, David Sutin, Jeff D Williamson, et al.
Plos One|April 4, 2012
Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT studyXue Zhang, Amy I Lynch, Barry R Davis, et al.
Journal of Hypertension|July 7, 2021
Sustained SBP control and long-term nursing home admission among Medicare beneficiariesC Barrett Bowling, Richard Sloane, Carl Pieper, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 8, 2006
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Linda B Piller, Charles E Ford, Barry R Davis, et al.
Drugs & Aging|August 7, 2015
Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-AnalysisMonica Teng, Liang Lin, Ying Jiao Zhao, et al.
Journal of General Internal Medicine|February 10, 2021
Association of Sustained Blood Pressure Control with Lower Risk for High-Cost Multimorbidities Among Medicare Beneficiaries in ALLHATC Barrett Bowling, Richard Sloane, Carl Pieper, et al.
Circulation|June 22, 2005
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) studyDonna K Arnett, Barry R Davis, Charles E Ford, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|May 1, 2014
Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real?Ravi V Shah, Siddique A Abbasi, José-Miguel Yamal, et al.
Journal of Hypertension|February 28, 2022
The Blood Pressure Lowering Treatment Trialists' Collaboration: methodological clarifications of recent reportsMilad Nazarzadeh, Dexter Canoy, Zeinab Bidel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 12, 2013
Visit-to-visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly ProgramJohn B Kostis, Jeanine E Sedjro, Javier Cabrera, et al.
Pageof 19